Table 2.

Tuberculosis (TB) chemoprophylaxis status throughout this study of the psoriasis patients with newly diagnosed latent tuberculosis infection

	n	%
Chemoprophylaxis
Complete chemoprophylaxis	252	62.2
Incomplete chemoprophylaxis	41	10.1
No chemoprophylaxis	112	27.7
Reason for incomplete chemoprophylaxis
Hepatic toxicity to anti-TB	31	75.6
Other toxicity to anti-TBa	1	2.4
Skin adverse drug eruptionb	8	19.6
Non-compliance of the patient	1	2.4
Reason for no chemoprophylaxis
Physician decision	99	88.4
Drug interaction	2	1.8
Patient decision	11	9.8

^aPeripheral neuropathy

^bMaculopapular rash